Telehealth refers to the use of electronic information and telecommunications technologies to support clinical healthcare, patient and professional health-related education, public health, and health administration. Services may include, but are not limited to:
Through the Reaux Health Platform, most consultations are conducted asynchronously: your Provider reviews your intake information, medical history, and questionnaire responses and determines a treatment plan without a real-time video encounter, unless the Provider determines that a synchronous visit is clinically necessary.
Reaux Health operates in compliance with the Illinois Telehealth Act (410 ILCS 151/) and applicable Illinois Department of Financial and Professional Regulation (IDFPR) rules governing telehealth practice. Under Illinois law:
As services expand to additional states, applicable telehealth laws of those states will govern the Provider-patient relationship in those jurisdictions.
Telehealth offers the following potential benefits:
You acknowledge and understand the following risks and limitations inherent to telehealth services:
Your Provider will use professional clinical judgment to determine whether your healthcare needs can be appropriately addressed via telehealth.
Reaux Health uses a HIPAA-compliant Electronic Medical Records platform (Healthie) for all clinical communications, records storage, and Provider-patient messaging. We have entered into Business Associate Agreements with all applicable vendors. Security measures include:
You are responsible for maintaining the security of your own device and account credentials. You should use the Platform only on trusted, secure networks and devices.
You may be asked to provide photos, such as a photo of yourself, an injection site, or your medication, as part of your evaluation or ongoing care. Submission of photos is voluntary, but may be necessary for your Provider to make appropriate clinical decisions.
Photos and any video communications are stored in your secure patient record and are subject to our Privacy Policy and HIPAA. We do not use photos or videos for marketing without your separate, written authorization.
If your Provider conducts a synchronous video visit with you, that visit may be recorded for clinical documentation. You will be informed before any recording occurs and have the right to decline.
All Providers offering telehealth services through the Platform are independently licensed healthcare professionals holding valid, active licenses in the state(s) in which they practice and in which you are located at the time of service. You agree to accurately represent your location when using the Platform, as Provider licensure requirements are state-specific.
Reaux Health verifies Provider credentials but does not employ, supervise, or direct the clinical decisions of affiliated Providers. Providers exercise independent professional judgment in all clinical matters.
Where clinically appropriate, your Provider may prescribe medications via telehealth. You acknowledge that:
Reaux Health's affiliated Providers prescribe compounded GLP-1 receptor agonist medications (semaglutide, tirzepatide) for weight management when clinically appropriate. You acknowledge and understand the following considerations specific to GLP-1 therapy:
Treatment is intended for adults who meet clinical criteria determined by your Provider, typically a Body Mass Index (BMI) of 30 or greater, or BMI of 27 or greater with at least one weight-related condition (such as type 2 diabetes, hypertension, dyslipidemia, or sleep apnea). Your Provider will determine whether you qualify based on your full clinical profile.
GLP-1 medications are contraindicated for individuals with any of the following:
You must disclose any of these conditions during intake. Failure to disclose contraindications may result in serious harm.
GLP-1 medications are not recommended during pregnancy or breastfeeding. If you are pregnant, trying to become pregnant, or breastfeeding, you must inform your Provider, who will not initiate or continue GLP-1 therapy in these circumstances. If you become pregnant during treatment, contact your Provider immediately.
GLP-1 medications are associated with the following potential adverse effects. By proceeding with treatment, you acknowledge that you have been informed of these risks:
Your Provider may require baseline and periodic lab work, which may include comprehensive metabolic panel, lipid panel, liver function tests, kidney function tests, and HbA1c, to monitor your safety and treatment response. Failure to complete required lab work may result in treatment discontinuation.
GLP-1 medications are typically initiated at a low dose and increased gradually to minimize side effects. You agree to report any concerning symptoms, particularly severe abdominal pain, persistent vomiting, signs of allergic reaction, or any unexpected symptoms, to your Provider promptly via the patient portal.
The medications prescribed through the Reaux Health Platform are compounded by state-licensed compounding pharmacies in coordination with your Provider. You acknowledge:
Compounded medications, including the compounded semaglutide and tirzepatide that may be prescribed through the Platform, are not FDA-approved. While brand-name versions (Wegovy®, Ozempic®, Zepbound™, Mounjaro®) are FDA-approved, compounded versions are prepared by individual pharmacies and have not undergone FDA review for safety or efficacy.
Active pharmaceutical ingredients used by partner compounding pharmacies are sourced from manufacturers registered with the FDA. Compounding pharmacies follow United States Pharmacopeia (USP) compounding standards (USP <795> and USP <797>).
Compounded versions are not generic equivalents and may differ from brand-name medications in formulation, excipients, or concentration. They are not direct substitutes for FDA-approved products.
Your Provider's decision to prescribe a compounded medication is independent and based on clinical judgment. The decision to accept and use a compounded medication is yours, made with your Provider's clinical guidance.
You may withdraw your consent to receive telehealth services at any time by notifying your Provider or Reaux Health in writing via the patient portal. Withdrawal of consent to telehealth will effectively end your ability to receive clinical services through the Platform. Withdrawal does not affect care already received or financial obligations already incurred.
If you prefer, you may seek the same or similar clinical services through in-person healthcare providers in your geographic area. Your Provider can assist with referrals to in-person care when clinically appropriate or upon your request.
The Reaux Health Platform is not designed for medical emergencies and must not be used as a substitute for emergency care.
If you are experiencing a medical emergency, you should:
Emergency warning signs that require immediate in-person care include: chest pain or pressure, difficulty breathing, stroke symptoms, severe allergic reactions, loss of consciousness, or uncontrolled bleeding.
To effectively use telehealth services through the Platform, you should have:
If you experience technical difficulties, contact Platform support at support@reauxhealth.com.
By enrolling in a Reaux Health subscription, you acknowledge that:
You acknowledge that the information you provide during intake, including medical history, current medications, current health status, contraindications, pregnancy status, and your physical location at the time of service, is accurate, complete, and truthful to the best of your knowledge. You agree to update your Provider promptly if any of this information changes during treatment. False, misleading, or incomplete information may result in serious harm and may result in immediate termination of your subscription without refund.
By accepting this Telehealth Consent Agreement electronically through the Reaux Health Platform during intake, you acknowledge and agree that:
This Telehealth Consent Agreement is governed by the laws of the State of Illinois and applicable federal telehealth regulations. For questions, contact support@reauxhealth.com.
